Pharmabiz5h
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy: Our Bureau, ...
Pharmabiz6h
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients: Our Bureau, Mumbai ...
Pharmabiz4h
Vivoryon Therapeutics provides R&D-update further strengthening development pipeline in kidney disease
Vivoryon Therapeutics provides R&D-update further strengthening development pipeline in kidney disease: Munich, Germany Wednesday, January 15, 2025, 18:00 Hrs [IST] Vivoryon Thera ...
Pharmabiz5h
Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research
Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research: Our Bureau, Bengaluru Wednesday, January 15, 2025, 17: ...
Pharmabiz7h
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy: Pratteln, Switzerland Wednesday, January 15, 2025 ...
Pharmabiz5h
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2: Maryland Wednesday, January 15, 2025, 17:00 Hrs [IST] New findings from the National Institutes of Health’s ...
Pharmabiz6h
Illumina & NVIDIA collaborate to decode biology and propel precision health
Illumina & NVIDIA collaborate to decode biology and propel precision health: San Diego Wednesday, January 15, 2025, 16:00 Hrs [IST] Illumina, Inc., a global leader in genomic sequ ...
Pharmabiz10h
REGENXBIO & Nippon Shinyaku enter exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases
Rockville, Maryland Wednesday, January 15, 2025, 12:00 Hrs [IST] ...
Pharmabiz11h
Regeneron announces adjuvant Libtayo significantly improves DFS after surgery in high-risk CSCC in phase 3 trial
Regeneron announces adjuvant Libtayo significantly improves DFS after surgery in high-risk CSCC in phase 3 trial: Tarrytown, New York Wednesday, January 15, 2025, 11:00 Hrs [IST] ...
Pharmabiz10h
SATB launches ‘Addressing The Twin Epidemics: Survivor Led Framework’ to integrate mental health and TB care
Our Bureau, Mumbai Wednesday, January 15, 2025, 11:30 Hrs [IST] ...
Pharmabiz13h
Daiichi Sankyo to pay $132.5 million to acquire IP rights for anti-TAMUC1 antibody in DS-3939 from Glycotope
Daiichi Sankyo to pay $132.5 million to acquire IP rights for anti-TAMUC1 antibody in DS-3939 from Glycotope: Tokyo Wednesday, January 15, 2025, 09:00 Hrs [IST] Daiichi Sankyo Com ...
Pharmabiz12h
Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm
Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm: Tokyo Wednesday, January 15, 2025, 10:00 Hrs [IST] Chugai P ...